Status:
COMPLETED
Dose-varied Evaluation of Ablavar-enhanced MR Angiography of the Central Veins of the Chest in Healthy Participants
Lead Sponsor:
Duke University
Collaborating Sponsors:
Lantheus Medical Imaging
Conditions:
Healthy
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
The purpose of this study is to assess the image quality of Ablavar-enhanced MR angiography of the central veins of the chest, and to determine whether dose reduction can be performed while maintainin...
Eligibility Criteria
Inclusion
- healthy male or female subjects between 18-45 years of age
Exclusion
- Pregnant and lactating females
- known renal impairment
- allergy to gadolinium-based contrast
- metallic implanted devices
- claustrophobia.
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01431300
Start Date
August 1 2011
End Date
July 1 2013
Last Update
December 10 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Medical Center
Durham, North Carolina, United States, 27710